Latest Content

Tamron Little was diagnosed with peritoneal mesothelioma after childbirth and now, 18 years later, she says survivorship is lifelong.

Participating in the SUNRiSE-1 trial taught Bill the value of education, teamwork, and persistence for patients with bladder cancer.

For Silvia Davis, a breast cancer diagnosis at the age of 36 led to a fertility preservation journey that resulted in her son, John.

Cancer has taught me to be vigilant, but also to be grateful — for modern science, for watchdog organizations, for the ability to access information instantly.

Dr. Anjana Pillai says treatment depends on stage and health, with surgery, transplant, local therapy or systemic drugs to help people live longer.

An expert discusses why up to 60% of new trial sites close in year one and what this means for patient access and research supply.

It wasn’t that I never expected a breast cancer diagnosis, it was that I had never even considered a breast cancer diagnosis.

Dr. Vinayak Venkataraman recently sat down with CURE to discuss the evolving treatment landscape for gastrointestinal stromal tumors.

The U.S. FDA has granted orphan drug designation to DPTX3186, an investigational therapy being developed for gastric cancer treatment.

No diet, supplement or vaccine can take away all risk. But using proven approaches gives me a sense of control and confidence.

Emerging investigational agents may shift the current standard of care for patients with the rare sarcoma known as gastrointestinal stromal tumors.

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as survivorship becomes a key focus.

Chester Freeman shares how the Japanese philosophy of wabi-sabi helped him embrace his scar and find beauty in imperfection while living with leukemia.